Citadel Advisors
GDRX icon

Citadel Advisors’s GoodRx Holdings GDRX Stock Holding History

Citadel Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Sell
104,218
-123,365
-54% -$314K ﹤0.01% 11125
2026
Q1 		$446K Buy
227,583
+193,529
+568% +$454K ﹤0.01% 9568
2025
Q4 		$92.3K Sell
34,054
-1,521,044
-98% -$4.99M ﹤0.01% 11704
2025
Q3 		$6.58M Sell
1,555,098
-68,138
-4% -$300K ﹤0.01% 3884
2025
Q2 		$8.08M Buy
1,623,236
+874,913
+117% +$3.8M ﹤0.01% 3340
2025
Q1 		$3.3M Buy
748,323
+183,307
+32% +$860K ﹤0.01% 4592
2024
Q4 		$2.63M Buy
565,016
+329,622
+140% +$1.81M ﹤0.01% 5071
2024
Q3 		$1.63M Sell
235,394
-55,841
-19% -$438K ﹤0.01% 5890
2024
Q2 		$2.27M Buy
291,235
+154,336
+113% +$1.14M ﹤0.01% 5073
2024
Q1 		$972K Sell
136,899
-13,545
-9% -$89.6K ﹤0.01% 6967
2023
Q4 		$1.01M Sell
150,444
-22,751
-13% -$128K ﹤0.01% 6660
2023
Q3 		$975K Sell
173,195
-923,155
-84% -$6.15M ﹤0.01% 6594
2023
Q2 		$6.05M Buy
1,096,350
+640,874
+141% +$3.45M ﹤0.01% 3347
2023
Q1 		$2.85M Sell
455,476
-165,163
-27% -$921K ﹤0.01% 4728
2022
Q4 		$2.89M Buy
620,639
+596,192
+2,439% +$2.94M ﹤0.01% 4801
2022
Q3 		$114K Sell
24,447
-454,995
-95% -$2.87M ﹤0.01% 10981
2022
Q2 		$2.84M Buy
479,442
+423,994
+765% +$4.72M ﹤0.01% 4856
2022
Q1 		$1.07M Buy
55,448
+5,135
+10% +$118K ﹤0.01% 7534
2021
Q4 		$1.64M Buy
50,313
+2,970
+6% +$119K ﹤0.01% 6683
2021
Q3 		$1.94M Sell
47,343
-248,822
-84% -$9.03M ﹤0.01% 6429
2021
Q2 		$10.7M Buy
296,165
+156,805
+113% +$5.79M ﹤0.01% 2976
2021
Q1 		$5.44M Buy
139,360
+53,797
+63% +$2.42M ﹤0.01% 4071
2020
Q4 		$3.45M Sell
85,563
-17,899
-17% -$822K ﹤0.01% 4341
2020
Q3 		$5.75M Buy
+103,462
New +$5.48M ﹤0.01% 2955

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Citadel Advisors's GDRX Position: Q2 2026 in Review

Citadel Advisors reduced its GoodRx Holdings (GDRX) stake by 54% in Q2 2026, selling an estimated $314K and leaving 104,218 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #11125.

Citadel Advisors first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.7M in Q2 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Citadel Advisors held 104,218 shares of GoodRx Holdings worth $300K as of Q2 2026.
  • Citadel Advisors sold 123,365 GoodRx Holdings shares in Q2 2026, an estimated $314K.
  • GoodRx Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11125 holding.
  • Citadel Advisors first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • Citadel Advisors's GoodRx Holdings position peaked at $10.7M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.